Pavlo Prudnikov

Pavlo Prudnikov

Auto-generated profile, based on publicly available information

Pavlo Prudnikov

Ivano-Frankivsk National Medical University of the Ministry of Health of Ukraine

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2022 in Perinatology and Reproductology: From Research to Practice
Verified
Journal Article
Closed access
SOSvitlana Ostafiichuk
Svitlana Ostafiichuk
PPPavlo Prudnikov
Pavlo Prudnikov
YMYuliya Motsyuk
Yuliya Motsyuk
The objective: to evaluate the psycho-emotional state, lifestyle changes, clinical symptoms and treatment measures in women with genital endometriosis after COVID-19 disease. Materials and methods. The study involved 120 women with genital endometriosis. The main group included 62 women with genital endometriosis after COVID-19 disease, the control group consisted of 58 patients with genital endometriosis, no symptoms of COVID-19 and negative PCR test at the time of examination. Impact of Covid-19 on lifestyle changes, symptoms and treatment of endometriosis was measured with a questionnaire. Pain assessment was performed by a visually analog scale (VAS). The psychoemotional state of women was analyzed by a Peritraumatic Distress Inventory. Statistical analyses based on Microsoft Excel statistical analysis package and “Statistica 7.0”(StatSoft Inc., USA). Results. The scientific work demonstrated high level of peritraumatic stress, lifestyle changes (decreased physical activity, increased sleepiness), worsening of clinical manifestations (increased fatigue, severe menstrual bleeding, dysmenorrhea, increased pelvic pain) and changes in treatment measures (increased analgesics and non-steroidal anti-inflammatory drugs using, discontinuation of hormonal therapy) in women with genital endometriosis after COVID-19 disease compared with group of women with genital endometriosis and without symptoms of coronavirus infection. Conclusions. The obtained results are necessary to optimize the management of patients with genital endometriosis and COVID-19.

30 September 2022 in Medicni perspektivi
Verified
Journal Article
Open access
PDF file
SOS.O. Ostafiichuk
S.O. Ostafiichuk
PVP.R. Volosovskiy
P.R. Volosovskiy
PPP.M. Prudnikov
P.M. Prudnikov
NHN.I. Henyk
N.I. Henyk
OMO.M. Makarchuk
O.M. Makarchuk
The goal of this study was to determine the association of hyperemesis gravidarum with the risk of development small for of fetus gestational age (SGA). Materials and methods. There were studied 327 pregnant women. The main group included 218 women with hyperemesis gravidarum, who were divided into two groups: 140 patients who were first hospitalized with hyperemesis gravidarum in the first trimester (up to 12 weeks of pregnancy) and 78 - who were first hospitalized with hyperemesis gravidarum in the second trimester (12-21 weeks of pregnancy). 109 pregnant women without vomiting were at control group. The diagnosis of SGA fetus was established on the basis of standard ultrasonic fetometry on the ALOKA SSD-1700. Determination of human serum chorionic gonadotropin (HCG) levels was performed at 15-20 weeks and was evaluated as MoM. The results were statistically analyzed using Statistica 10 (Serial Number: STA999K347150-W) and MEDCALC®. Results. In the main group, the SGA fetus was 3.4-fold more frequent compared with pregnant women in the control group (9.6% vs. 2.8%, p0.05). However, hyperemesis gravidarum in pregnant women in the second trimester increases the risk of developing SGA fetus (OR=6.42; 95%CI 1.75-23.62; p<0.01) compared with control. Pregnant women with HCG≥2.5 MoM were 3.0-fold more likely to be diagnosed SGA fetus than with HCG<2.5 MoM (75.0% vs. 25.0%, p<0.001; OR=9.00; 95%CI:1.42-57.12) and 2.3-fold compared with the development of the normal fetus (75.0% vs. 33.3%, p<0.001; OR=6.00; 95%CI:1.47-24,4). Conclusion. Hyperemesis gravidarum in the second trimester of pregnancy and elevation of HCG level in the second trimester (≥2,5 МоМ) can be seen as markers of placental disfunction and high risk for SGA fetus.

9 April 2022 in Art of Medicine
Verified
Journal Article
Open access
PDF file
SOS. O. Ostafiichuk
S. O. Ostafiichuk
PVP. R. Volosovskyi
P. R. Volosovskyi
PPP. M. Prudnikov
P. M. Prudnikov
NHN. I. Henyk
N. I. Henyk
The problem of optimizing the management of women with chronic pelvic pain syndrome (CPP) is actual due to the high frequency of this pathology, unclear many aspects of the pathogenesis, negative impact on quality of life, as well as difficulties in diagnosing the leading factor and effective treatment. Aim. Optimization of the diagnostic algorithm of managing women with chronic pelvic pain (CPP) and pelvic congestion syndrome (PCS). Materials and methods. A prospective study was carried out at Ivano-Frankivsk City Clinical Perinatal Center, Ukraine. 112 patients with CPP and 53 women without pain and symptoms of gynecological pathology as a control group have been included. Exclusion criteria are as follows: pelvic tumors, genital endometriosis, acute inflammatory diseases of the pelvic organs and specific inflammatory diseases of the pelvic organs. Clinical and laboratory examination, ultrasound and Doppler ultrasound of the main pelvic veins: uterine, ovarian, internal iliac and arcuate veins, Valsalva᾽s test have been performed, which helps to detect venous diameter and reflux, for all patients. Short Pain Assessment Scale, the McGill Pain Questionnaire (SF-MPQ), and the Visual Analog Scale (VAS) were used for pain assessment. The tests were conducted in the form of interviews and questionnaires. The results were statistically analyzed using Statistica 7.0 program pack (StatSoft Inc., USA) and Microsoft Excel statistical analysis package. The differences between the selections were considered statistically reliable at p<0.05 (Tukey’s test). Results. Pain duration, examination and treatment of chronic pelvic inflammatory disease were in average 3.8±2.4 years at the time of the first visit. The study has proved that the risk factors for CPP and PCS are high parity (3 or more deliveries), prolonged work in prolong standing or sitting position, interrupted intercourse. 69.6 % of women noted a deterioration in general activity, 43.8 % impaired gait, 79.5 % had difficulties in performing daily work and professional activities, 71.4 % of patients had increased pain in the second phase of the menstrual cycle, and in 83.9 % after prolonged standing. Half of women have sleep disorders, 80.4 % – emotional lability, a third group have periods of depression, and 71.4 % – a negative impact on sexual life according to the results of a Short Pain Assessment Scale. Based on SF-MPQ, it was found that the sensory characteristics of pain were different. 69 (61.6 %) women had convulsive, aching and moderate pain, 16.1 % – severe and burning pain, 8.9% of patients suffered on prickly pain. Evaluation of the emotional scale showed that PCS caused exhaustion in more than half of women, nausea in a third of cases, while 5 (4.5 %) patients reported severe pain that led to despair. Pain intensity due to VAS was 4.44±1.15. Ultrasound revealed an increased diameters of the main pelvic venous collectors, decreased peak systolic bleeding rate in women with CPP and PCS compared with the results of women of the control group (p<0,05). Valsalva᾽s test showed that the presence of reno-ovarian reflux was found in 15.2 % patients of the main group, including bilateral in 23.53 %, isolated left – in 64.7 %. Conclusions. Women with CPP, especially in the presence of risk factors and the specific clinical picture of pelvic congestion should undergo ultrasound and Doppler ultrasound examination of the uterine, ovarian, internal iliac and arcuate veins. Pain assessment scales have the prognostic value of routine pain assessment to analyze the treatment results. Цель: Оптимизация диагностического алгоритма ведения женщин с хронической тазовой болью (ХТБ) и застойным тазовым синдромом (ТЗС). Материалы и методы: Обследовано 112 пациенток с ХТБ и ТЗС. Контрольную группу составили 53 женщины без боли и симптомов гинекологической патологии. Проведено клинико-лабораторное обследование, ультразвуковое исследование (УЗИ) и доплерометрия основных вен малого таза: маточных, яичниковых, внутренних подвздошных и аркуатных вен, проба Вальсальвы. Оценку боли проводили по короткой школе оценки боли, опроснику боли Мак Гилла (SF-MPQ) и визуально аналоговой шкале (ВАШ). Полученный цифровой материал обрабатывали статистически с использованием пакета статистического анализа на базе Microsoft Excel и программы Statistica 7.0 (StatSoft Inc., USA). Результаты: Установлено, что факторами риска возникновения ХТБ на фоне ТЗС являются высокий паритет (3 и более родов), длительная работа в вынужденном стоячем и сидячем положениях, прерваный половой акт. 69,6 % обследованных женщин отмечали ухудшение общей активности, 43,8 % нарушение ходьбы, у 79,5 % были трудности при выполнении повседневного труда и профессиональной деятельности, у 71,4 % пациенток боль усиливалась во второй фазе менструального цикла, а у 83,9 % после продолжительного стояния. У половины женщин отмечено нарушение сна, у 80,4 % –...

25 September 2023 in Perinatology and Reproductology: From Research to Practice
Verified
Journal Article
Open access
PDF file
OMOksana Makarchuk
Oksana Makarchuk
OOOksana Ostrovska
Oksana Ostrovska
MRMariana Rymarchuk
Mariana Rymarchuk
IOIryna Orishchak
Iryna Orishchak
NHNatalia Henyk
Natalia Henyk
SOSvitlana Ostafiichuk
Svitlana Ostafiichuk
Summary. One of the most severe consequences of endometrial hyperplasia in the reproductive age is infertility, and the fact of miscarriage and an increase in the rate of spontaneous abortions in obesity is currently proven. The aim of the study is to evaluate the effectiveness of an optimized program of preconception care and pregnancy monitoring in patients with impaired reproductive function against the background of endometrial hyperplasia and obesity. Research materials and methods. All 100 women with impaired reproductive function against the background of endometrial hyperplasia and BMI>30 kg/m2 underwent a comprehensive clinical and laboratory examination and were divided into two groups by the method of blind sampling: the main group included 50 patients, who were offered an optimized program of preconception care, and the comparison group consisted of 50 women who received traditional folate therapy. The effectiveness of therapeutic options and rehabilitation measures was evaluated 3 months after the completion of the endometrial pathology treatment program and monitored during the year based on the results of natural fertility cycles, cycles of the IVF program, taking into account the proportion of pregnancy complications, its consequences and the percentage of live births. Research results and their discussion. Pregnancy in overweight women is accompanied by a higher percentage of early reproductive loss (20.0%), preterm birth (16.0%), preeclampsia, especially severe form (45.0%), placental dysfunction, and low birth weight babies (15.0%), as well as failed IVF program attempts. Out of 100 examined patients with endometrial hyperplasia against the background of a violation of fat metabolism, 15 patients (15.0%) decided to postpone reproductive plans, 32 women (32.0%) were offered an IVF program after two unsuccessful ovulation inductions in a natural fertility cycle, 43 patients (43.0%) had a spontaneous pregnancy, 10 women (10.0%) did not get pregnant. At the time of the analysis of the final conclusions, it should be noted a 1.9 times higher share of spontaneous pregnancy, a 2.1 times higher share of successful IVF attempts, a 1.5 times higher share of live births, and 4.2 times less reproductive failures. The risk of retrochorial hematoma in the comparison group increases 4.1 times (OR=4.14, 95% CI: (1.30-13.21; p<0.05), as well as the risk of early reproductive losses (OR= 3.12, 95% CI: (1.21-8.02; p<0.05), and the possibility of successful termination of pregnancy in the main group exceeds such data in the comparison group by 6.0 times (OR=6.0, 95%, CI: (1.75-20.62; p<0.05). Conclusions. Careful monitoring and diagnostic algorithm in patients with endometrial hyperplasia, as a significant factor in subfertility, allows choosing a rational personalized approach to the use of minimally invasive visual techniques and rehabilitative therapeutic options for restoring the morphofunctional state of the endometrium and metabolic parameters, as well as developing adequate preconception care, reducing probable reproductive losses in 4.2 times and creating prerequisites for a 1.5-fold increase in the proportion of live births in this category of patients.

25 July 2023 in Art of Medicine
Verified
Journal Article
Open access
PDF file
OMO. M. Makarchuk
O. M. Makarchuk
MRM. I. Rymarchuk
M. I. Rymarchuk
OOO. M. Ostrovska
O. M. Ostrovska
IOI. K. Orishchak
I. K. Orishchak
NHN.I. Henyk
N.I. Henyk
SOS. O. Ostafiychuk
S. O. Ostafiychuk
According to the WHO, every second woman has a problem with excess weight, while about 23% of women indicate a pathological body mass index, and excess weight (the so-called “pre-obesity”) is noted in 25% of women. The aim of the research was to evaluate the structural and functional parameters of the endometrium and ovarian tissue and to optimize the diagnostic algorithm and monitoring of the endometrium in women with obesity and impaired reproductive function. Materials and methods. 110 patients of reproductive age with impaired reproductive health underwent a comprehensive clinical and laboratory examination within the framework of this research. The main group included 64 patients with overweight and class 1 obesity, and the comparison group consisted of 46 women with a normal body mass index. The proposed diagnostic algorithm included a sonographic study of the structural parameters of the endometrium and ovaries, as well as an assessment of the features of the blood supply to the pelvic organs and statistical processing of the results. Research results and their discussion. The presented results allow us to note a significant percentage of comorbidity of somatic and gynecological pathology in overweight and obese patients. Pregnancy is accompanied by a higher percentage of early reproductive losses (14.0%), preterm birth (10.9%), preeclampsia (42.2%), placental dysfunction (46.4%) and low birth weight (17.2%). The main clinical forms of endometrial pathology in the main group were polyposis (32.8%), endometrial hyperplasia (23.4%) and dyschronosis of morphological changes of the endometrium (28.1%). The combination of endometrial hyperplasia with/or uterine leiomyoma, adenomyosis, benign ovarian tumors and retention formations was noted in 53.6% of observations in both groups; in 46.4% of women the isolated form was noted. The morphological characteristics of endometrial polyposis allowed us to note the dominance of glandular-fibrous polyps (45.2%) and in the case of a combination with myoma or ovarian retention cysts - glandular forms (32.3%). The most frequent sonographic marker of dysfunction of the endometrial potential (inconsistency of the ultrasound image of the endometrium with the phase of the menstrual cycle) was revealed in more than half of the cases (62.5%). Sonographic evaluation of the structural parameters of the endometrium and ovarian tissue showed an increase in the anterior-posterior size of the uterus and the thickness of the endometrium by 2.8 times, the volume of the ovary – by 2.0 times. It should be noted that the patients of the main group had a greater proportion of cysts and endometriomas. According to dopplerometry data, significantly lower parameters of the vascular resistance index were confirmed in the ovarian arteries and in the arteries of the stroma; in almost half of the observations, varicose veins of the parametrium were noted. Conclusions. Changes in steroidogenesis against the background of lipid metabolism disorders are accompanied by an increase in the volume of the endometrium and ovarian tissue, growing proportion of cystic formations in the appendages, an increase in the hemodynamic imbalance of blood flow in pelvic organs, which requires optimization of the monitoring program at the stage of preconception preparation and elimination of risk factors for placental dysfunction.

29 June 2026
Verified
Journal Article
Open access
NHN. Henyk
N. Henyk
RBR. Bihun
R. Bihun
PPP. Prudnikov
P. Prudnikov
OPO. Perkhulyn
O. Perkhulyn
LML. Maxymenko
L. Maxymenko
MMM. Morenko
M. Morenko
The proportion of women with overweight or obesity has increased steadily over the past two decades, representing a concerning trend for pregnancy outcomes. Excess weight represents an important risk factor for pregnancy complications, including preeclampsia, eclampsia, gestational diabetes mellitus, gestational hypertension, and disorders of placental development and implantation. Overweight and obesity are closely associated with oxidative stress, insulin resistance, and altered nitric oxide bioavailability. The aim of this study. To investigate the principal metabolic and endothelial disturbances and establish their association with adverse pregnancy outcomes in women with overweight. Materials and methods. Sixty-eight pregnant women with overweight and 49 pregnant women with normal BMI were included in the study. Endothelial dysfunction was assessed by measuring serum levels of endothelin-1 and nitric oxide (NO) using enzyme immunoassay. Dynamic monitoring of endothelial dysfunction markers was performed throughout pregnancy in women with elevated and normal baseline BMI. Informed consent in written form was secured from all study participants prior to enrollment. Data were analyzed using Microsoft Excel and Statistica 12.0 software (StatSoft Inc., USA). Pearson's correlation coefficient was used for correlation analysis. Normality of distribution was assessed using the D'Agostino and Shapiro–Wilk tests, with normal distribution confirmed in most groups (p > 0.05). Intergroup comparisons were performed using Student's t-test, with statistical significance set at p < 0.05. The study protocol was approved by the Ethics Committee of Ivano-Frankivsk National Medical University (Protocol No. 118/20, dated December 15, 2020) and conducted at the Municipal Clinical Perinatal Center of the Ivano-Frankivsk City Council, Ivano-Frankivsk, as part of the comprehensive research project "Development of diagnostic strategies and pathogenetic justification of effective methods for preserving and restoring reproductive potential and improving quality of life parameters in women with obstetric and gynecological pathologies" (No. 0121U109269). Results. During the first trimester, pregnant women with overweight demonstrated vasoconstrictor ET-1 levels 2.3-fold higher and NO metabolite concentrations 1.3-fold lower than those observed in the normal-BMI group (p < 0.05 for both). Longitudinal assessment revealed a significant decline in NO metabolite concentrations by late pregnancy relative to the first trimester, with reductions of 1.2-fold, 1.1-fold, and 1.2-fold in pregnancies resulting in recommended, insufficient, and excessive fetal weight, respectively (all p < 0.05). Within the subgroup characterized by excessive gestational weight gain, NO levels were further reduced by 1.2-fold compared with the normal-weight-gain subgroup (p < 0.05). Among women who subsequently developed gestational hypertension or preeclampsia and who had overweight during the pre-conception period, vasoconstrictor ET-1 production was increased 1.6-fold and 1.7-fold, respectively, relative to women with normal BMI (both p < 0.05), with NO levels correspondingly lower in both outcome groups among women with overweight compared with their normal-BMI counterparts (p < 0.05). During the first trimester, women with overweight who later developed gestational hypertension exhibited vasoconstrictor ET-1 levels 1.9-fold higher and NO metabolite concentrations 1.2-fold lower than pregnant women with normal BMI (both p < 0.05). At 11–13 weeks' gestation, a comparable pattern was observed in women with overweight who subsequently developed gestational diabetes, with vasoconstrictor ET-1 concentrations 1.7-fold higher and NO metabolite levels 1.3-fold lower than in women with normal BMI (both p < 0.05). Conclusions. Overweight in pregnancy is strongly associated with elevated markers of endothelial dysfunction, characterized by increased pro-oxidant system activity and reduced antioxidant system activity. Endothelial dysfunction marker levels in early pregnancy additionally demonstrate a strong correlation with the risk of subsequent gestational diabetes and hypertensive disorders in late pregnancy among women with overweight.